Acer Therapeutics Inc. ACER
0.66 +0.66
Day range unavailable
52-week range unavailable
- Earnings date
- Dec 23, 2024
No chart data for this range yet.
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Dec 23, 2024
Expected Dec 23, 2024. Consensus EPS estimate 0.00.
Financials — quick view
ACER Revenue — quarterly 0
ACER Net income — quarterly -8.09M
ACER EPS — quarterly -0.33
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 23, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Sep 30, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jul 1, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Nov 20, 2023 | Sep 1, 2023 | -0.13 | -0.53 | -0.40 | -307.69% |
| Aug 14, 2023 | Jun 1, 2023 | -0.26 | -0.23 | +0.03 | +11.54% |
News
Russian LNG on the rise in EU – report 
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals 
PC demand is back, says Acer CEO who sees robust growth in the 'foreseeable future' 
ACER THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acer Therapeutics Inc. - ACER 
ACER THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acer Therapeutics Inc. - ACER 
12 Health Care Stocks Moving In Tuesday's Intraday Session 
12 Health Care Stocks Moving In Friday's Intraday Session 
Why Olin Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session - 12 Health Care Stocks Moving In Friday's Pre-Market Session
Acer (ACER) to Get Acquired by Zevra for $91M, Stock Up
Your note
Sign in to keep a note on ACER — it syncs with the Stock Master app.